SciClone Pharmaceuticals Becomes Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of SciClone Pharmaceuticals, Inc. ( SCLN) entered into oversold territory, hitting an RSI reading of 27.5, after changing hands as low as $9.025 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 48.1. A bullish investor could look at SCLN's 27.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of SCLN shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

SciClone Pharmaceuticals, Inc. 1 Year Performance Chart

Looking at the chart above, SCLN's low point in its 52 week range is $7.37 per share, with $15.03 as the 52 week high point — that compares with a last trade of $9.05.

According to the ETF Finder at ETF Channel, SCLN makes up 1.08% of the iShares U.S. Pharmaceuticals ETF ( IHE) which is trading lower by about 0.4% on the day Thursday.

More from Stocks

Costco Stock Could Return to Its Early 2018 Low Area: Take Action

Costco Stock Could Return to Its Early 2018 Low Area: Take Action

There's More Market Uncertainty Up Ahead

There's More Market Uncertainty Up Ahead

Tax Loss Selling Recovery Candidates, Part 3

Tax Loss Selling Recovery Candidates, Part 3

Johnson & Johnson Shares Plunge After Report It Knew of Asbestos in Baby Powder

Johnson & Johnson Shares Plunge After Report It Knew of Asbestos in Baby Powder

Dow Falls Sharply as Weak China Data Worries Wall Street; J&J Shares Plummet

Dow Falls Sharply as Weak China Data Worries Wall Street; J&J Shares Plummet